GlassScriptPhysician profile
Roberto Andres Corpus
NPI 1417995432
$48,392.11
in general payments reported to CMS, 2019-2025
30 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,216 · 2020: $1,810 · 2021: $1,848 · 2022: $2,279 · 2023: $6,530 · 2024: $20K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $25K · Food and Beverage: $11K · Consulting Fee: $2,250 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $25,416.67 |
| Food and Beverage | $10,873.90 |
| Consulting Fee | $2,250.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $198.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $25,748.95 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $8,967.85 | 2019-2025 | Absolute Pro, Esprit, Diamondback Peripheral |
| Cardiovascular Systems INC. | $4,060.61 | 2019-2023 | Diamondback Peripheral |
| Philips North America LLC | $2,840.81 | 2019-2025 | (Bh4) Igt Devices Undivided, (4067) Tack Endovascular Systems Btk, Igt Devices Undivided |
| Bard Peripheral Vascular, INC. | $2,420.10 | 2019-2025 | Venovo, Venclose Maven Catheter, Lutonix Drug Coated Balloon |
| Terumo Medical Corporation | $895.12 | 2019-2023 | Glidesheath Slender, Navicross, Angio-Seal |
| Penumbra, INC. | $654.69 | 2019-2022 | |
| Amgen INC. | $582.47 | 2023-2025 | Repatha, Repatha |
| Inari Medical, INC. | $314.08 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $309.43 | 2023-2025 | |
| Globus Medical, INC. | $261.99 | 2025 | Senza |
| Janssen Pharmaceuticals, INC | $261.21 | 2023-2024 | Xarelto |
| Asahi Intecc USA, INC. | $185.29 | 2023 | Asahi Ptca Guide Wire |
| Medtronic, INC. | $144.09 | 2021-2023 | Abre |
| E.R. Squibb & Sons, L.L.C. | $137.82 | 2023-2025 | Eliquis, Camzyos |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $107.63 | 2023-2025 | |
| Medtronic Vascular, INC. | $81.01 | 2020 | |
| Cordis US Corp. | $65.86 | 2023-2025 | Saber, Radial 360 |
| Abbvie INC. | $56.94 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.21 | 2023 | Jardiance |
| Tactile Systems Technology INC | $50.02 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Alnylam Pharmaceuticals INC. | $41.44 | 2025 | Onpattro |
| Abiomed | $33.53 | 2020-2025 | |
| Smith+Nephew, INC. | $24.94 | 2024 | Pico |
| Irhythm Technologies, INC. | $24.57 | 2024 | Zio Xt Patch, Zio Monitor |
| Glaxosmithkline, LLC. | $20.86 | 2025 | Shingrix, Arexvy |
| Organogenesis INC. | $18.11 | 2023 | Puraply |
| Cardiva Medical, INC. | $16.12 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.36 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Corpus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.